🔎 Trials Near Me

Почетна › Неуробластом › Јужна Каролина

Kliničke studije za Неуробластом u državi Јужна Каролина

6 studija za Неуробластом traži učesnike na lokacijama u državi Јужна Каролина.

Gradovi u državi Јужна Каролина

Zvanični tekst studije (na engleskom)

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Medical University of South Carolina, Charleston
Тражи се учесникФаза 1/2
До 30 година · Оба пола · Ажурирано 12. 11. 2026. · NCT06541262

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

  • Prisma Health Richland Hospital, Columbia
Тражи се учесникФаза 1/2
Узраст од 1 до 30 · Оба пола · Ажурирано 6. 11. 2026. · NCT07437963

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Medical University of South Carolina, Charleston
  • Prisma Health Richland Hospital, Columbia
  • BI-LO Charities Children's Cancer Center, Greenville
Тражи се учесникФаза 3
До 30 година · Оба пола · Ажурирано 30. 10. 2026. · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Medical University of South Carolina, Charleston
Тражи се учесникФаза 2
До 22 година · Оба пола · Ажурирано 4. 9. 2026. · NCT02559778

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Medical University of South Carolina, Charleston
  • Prisma Health Richland Hospital, Columbia
  • BI-LO Charities Children's Cancer Center, Greenville
Тражи се учесникФаза 3
365 Days – 30 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03126916

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Medical University of South Carolina, Charleston
Тражи се учесникФаза 2
12 Months – 21 Years · Оба пола · Ажурирано 12. 8. 2026. · NCT05489887

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.